Publications by authors named "Toni Brand"

Claim this Profile
E
Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.
Toni M Brand, Stefan Hartmann, Neil E Bhola, Hua Li, Yan Zeng

Cancer Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.
Toni M Brand, Stefan Hartmann, Neil E Bhola, Hua Li, Yan Zeng

Cancer Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction.
Toni M Brand, Mari Iida, Kelsey L Corrigan, Cara M Braverman, John P Coan

Sci Signal· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV Patients.
Toni M Brand, Stefan Hartmann, Neil E Bhola, Noah D Peyser, Hua Li

Clin Cancer Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-negative Breast Cancer.
Toni M Brand, Mari Iida, Emily F Dunn, Neha Luthar, Kellie T Kostopoulos

Mol Cancer Ther· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression-mediated activation of MET in the Golgi promotes HER3/ERBB3 phosphorylation.
Nicole Michael Frazier, Toni Brand, John D Gordan, Jennifer Grandis, Natalia Jura

Oncogene· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for -altered head and neck cancer.
Matthew L Hedberg, Noah D Peyser, Julie E Bauman, William E Gooding, Hua Li, Toni M Brand

J Exp Med· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to: "Nuclear EGFR as a molecular target in cancer" [Radiother Oncol 108 (2013) 370-77].
Toni M Brand, Mari Iida, Neha Luthar, Megan M Starr, Evan J Huppert

Radiother Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma.
Toni M Brand, Mari Iida, Andrew P Stein, Kelsey L Corrigan, Cara M Braverman

Clin Cancer Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Routes to Oncogenesis Are Promoted by the Human Papillomavirus-Host Protein Network.
Manon Eckhardt, Wei Zhang, Andrew M Gross, John Von Dollen, Jeffrey R Johnson, Toni M Brand

Cancer Discov· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BET Inhibition Overcomes Receptor Tyrosine Kinase-Mediated Cetuximab Resistance in HNSCC.
Brandon Leonard, Toni M Brand, Rachel A O'Keefe, Eliot D Lee, Yan Zeng

Cancer Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.
Toni M Brand, Stefan Hartmann, Neil E Bhola, Hua Li, Yan Zeng

Cancer Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV Patients.
Toni M Brand, Stefan Hartmann, Neil E Bhola, Noah D Peyser, Hua Li

Clin Cancer Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RETRACTED: The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor.
Toni M Brand, Mari Iida, Kelsey L Corrigan, Cara M Braverman, John P Coan

Sci Signal· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab.
Mari Iida, Harsh Bahrar, Toni M Brand, Hannah E Pearson, John P Coan

Mol Cancer Ther· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive responses to antibody based therapy.
Tamara S Rodems, Mari Iida, Toni M Brand, Hannah E Pearson, Rachel A Orbuch

Semin Cell Dev Biol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma.
Toni M Brand, Mari Iida, Andrew P Stein, Kelsey L Corrigan, Cara M Braverman

Clin Cancer Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy.
Mari Iida, Toni M Brand, Megan M Starr, Evan J Huppert, Neha Luthar

Mol Cancer· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AXL mediates resistance to cetuximab therapy.
Toni M Brand, Mari Iida, Andrew P Stein, Kelsey L Corrigan, Cara M Braverman

Cancer Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancer.
Toni M Brand, Mari Iida, Emily F Dunn, Neha Luthar, Kellie T Kostopoulos

Mol Cancer Ther· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping C-terminal transactivation domains of the nuclear HER family receptor tyrosine kinase HER3.
Toni M Brand, Mari Iida, Neha Luthar, Matthew J Wleklinski, Megan M Starr

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancer.
Cleo E Rolle, Rajani Kanteti, Mosmi Surati, Suvobroto Nandi, Immanuel Dhanasingh, Toni M Brand

Mol Cancer Ther· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sym004, a novel EGFR antibody mixture, can overcome acquired resistance to cetuximab.
Mari Iida, Toni M Brand, Megan M Starr, Chunrong Li, Evan J Huppert

Neoplasia· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear EGFR as a molecular target in cancer.
Toni M Brand, Mari Iida, Neha Luthar, Megan M Starr, Evan J Huppert

Radiother Oncol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinoma.
Chunrong Li, Toni M Brand, Mari Iida, Shyhmin Huang, Eric A Armstrong

Discov Med· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis